Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bentonite Performance Minerals (BPM) is a leading producer of high-purity sodium bentonite clay, specifically processed for the pharmaceutical, personal care, and animal health industries. As a subsidiary of Halliburton, the company leverages extensive mineral reserves in Wyoming to manufacture USP/NF grade bentonite used as an excipient, stabilizer, and suspending agent in drug formulations. Their products are critical for applications ranging from gastrointestinal detoxifying agents to topical rheology modifiers in skincare and cosmetics. BPM provides technical expertise in clay chemistry to support the specialized formulation needs of global life science manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bentonite Performance Minerals.